Azure Healthcare Ltd (ASX:AZV) insider Clayton Astles acquired 298,364 shares of Azure Healthcare stock in a transaction that occurred on Thursday, April 4th. The stock was bought at an average price of A$0.07 ($0.05) per share, for a total transaction of A$19,393.66 ($13,754.37).

Shares of AZV opened at A$0.07 ($0.05) on Thursday. The stock has a market capitalization of $15.13 million and a P/E ratio of 65.00. Azure Healthcare Ltd has a 12-month low of A$0.05 ($0.03) and a 12-month high of A$0.11 ($0.07). The company has a debt-to-equity ratio of 4.38, a quick ratio of 0.93 and a current ratio of 1.85.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/azure-healthcare-ltd-azv-insider-clayton-astles-purchases-298364-shares/2954750.html.

Azure Healthcare Company Profile

Azure Healthcare Limited, together with its subsidiaries, manufactures, services, supplies, and distributes healthcare and electronic communications equipment in Australia, New Zealand, Asia, Europe, and North America. It offers Tacera, a nurse call and healthcare communication system for hospitals and aged care facilities; MediCom, a nurse call system for use in hospitals and nursing homes; and CellGuard that provides audio communication solution, including officer duress, cell intercom, discrete monitoring, door intercom, background music distribution, and public address announcements.

Read More: What is channel trading?

Receive News & Ratings for Azure Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azure Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.